Skip to main content

Natixis Advisors, L.P.

SEC CIK
0001018331
Latest filing
Aug 14, 2026

AZN holding history

AstraZeneca PLC in every 13F filed by Natixis Advisors, L.P., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AZN overviewAll 13F holders of AZNFull Q2 2026 holdings

Shares (Q2 2026)
1,978,508
Value
$375.2M
% of portfolio
0.4%
Quarters held
22
Since Q1 2021
Holdings of AZN by Natixis Advisors, L.P., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,978,508$375.2M0.4%+666,009+50.7%AddedHolders
Q1 20261,312,499$258.9M0.4%+285,744+27.8%AddedConverted for a 1-for-2 splitHolders
Q4 20252,053,511$188.8M0.3%−46,879−2.2%ReducedHolders
Q3 20252,100,390$161.1M0.2%+262,465+14.3%AddedHolders
Q2 20251,837,925$128.4M0.2%−398,086−17.8%ReducedHolders
Q1 20252,236,011$164.3M0.3%+175,813+8.5%AddedHolders
Q4 20242,060,198$135.0M0.3%+99,383+5.1%AddedHolders
Q3 20241,960,815$152.8M0.3%+117,162+6.4%AddedHolders
Q2 20241,843,653$143.8M0.3%+277,946+17.8%AddedHolders
Q1 20241,565,707$106.1M0.2%+315,089+25.2%AddedHolders
Q4 20231,250,618$84.2M0.2%+78,286+6.7%AddedHolders
Q3 20231,172,332$79.4M0.2%+37,668+3.3%AddedHolders
Q2 20231,134,664$81.2M0.3%+132,265+13.2%AddedHolders
Q1 20231,002,399$69.6M0.2%+119,228+13.5%AddedHolders
Q4 2022883,171$59.9M0.2%−21,730−2.4%ReducedHolders
Q3 2022904,901$49.6M0.2%+266,986+41.9%AddedHolders
Q2 2022637,915$42.1M0.2%−2,278−0.4%ReducedHolders
Q1 2022640,193$42.5M0.2%+47,865+8.1%AddedHolders
Q4 2021592,328$34.5M0.1%+340.0%AddedHolders
Q3 2021592,294$35.6M0.1%+100,623+20.5%AddedHolders
Q2 2021491,671$29.5M0.1%+72,770+17.4%AddedHolders
Q1 2021418,901$20.8M0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.